Rachman Ilya M
CEO and Chairman
Rachman Ilya M has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 10, 2025.
On the most recent filing, Rachman Ilya M is listed as CEO and Chairman at Immix Biopharma, Inc. Inside the rolling window, Rachman Ilya M reported 1 open-market purchase totaling $5K in IMMX and no open-market sales.
Companies traded
Other insiders at IMMX
Insider Buying
$5K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 17, 2025 | IMMX | Purchase | $5K |
Frequently asked questions
How many SEC Form 4 filings has Rachman Ilya M made?
Rachman Ilya M has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Rachman Ilya M trade?
Rachman Ilya M has filed SEC Form 4 disclosures for 1 company, including IMMX.
When was Rachman Ilya M's most recent SEC Form 4 filing?
Rachman Ilya M's most recent SEC Form 4 filing on Tracefour is dated Dec 10, 2025.
What is Rachman Ilya M's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rachman Ilya M is listed as CEO and Chairman.
What is Rachman Ilya M's total buy and sell value in the current window?
Inside the rolling retention window, Rachman Ilya M bought $5K and sold $0 based on SEC Form 4 filings.
What was Rachman Ilya M's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 746 IMMX shares on 2025-12-10, worth $5K, per SEC Form 4 filings.